about
Perioperative factors determine outcome after surgery for severe acute pancreatitisAcute Kidney Injury in Cardiorenal Syndrome Type 1 Patients: A Systematic Review and Meta-AnalysisImpact of electronic-alerting of acute kidney injury: workgroup statements from the 15(th) ADQI Consensus ConferenceClinical review: use of renal replacement therapies in special groups of ICU patientsAcute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference.Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup.Thrombocytopenia and outcome in critically ill patients with bloodstream infection.Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?Urinary output and fractional excretion of sodium and urea as indicators of transient versus intrinsic acute kidney injury during early sepsis.Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017 : Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine.Epidemiology of acute kidney injury.Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus.Implementing the Kidney Disease: Improving Global Outcomes/acute kidney injury guidelines in ICU patients.Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers.Severe burn injury in Europe: a systematic review of the incidence, etiology, morbidity, and mortalityAcute kidney injury survivors should have long-term follow-up.Tissue Inhibitor Metalloproteinase-2 (TIMP-2)⋅IGF-Binding Protein-7 (IGFBP7) Levels Are Associated with Adverse Long-Term Outcomes in Patients with AKI.Acute renal failure in the critically ill: impact on morbidity and mortality.Intermittent hemodialysis for acute renal failure patients--an update.Physiologic consequences of acute renal failure on the critically ill.Dynamics of C-reactive protein and white blood cell count in critically ill patients with nosocomial Gram positive vs. Gram negative bacteremia: a historical cohort studyA novel approach for prediction of tacrolimus blood concentration in liver transplantation patients in the intensive care unit through support vector regressionDecompressive laparotomy for abdominal compartment syndrome--a critical analysisCurrent pharmacotherapeutic recommendations for acute pancreatitis.Urinary chitinase 3-like protein 1 for early diagnosis of acute kidney injury: a prospective cohort study in adult critically ill patientsAKI patients have worse long-term outcomes, especially in the immediate post-ICU period.Acute kidney injury: epidemiology and diagnostic criteria.Incidence, classification, and outcomes of acute kidney injury.The epidemiology of cardiac surgery-associated acute kidney injury.Epidemiology of acute kidney injury: how big is the problem?Acute kidney injury: epidemiology and assessment.Acute kidney injury in critically ill patients with cancer.Clinical consequences of acute kidney injury.Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).Cardiorenal syndrome type 3: pathophysiologic and epidemiologic considerations.Four phases of intravenous fluid therapy: a conceptual model.Contrast-associated AKI in the critically ill: relevant or irrelevant?Phenytoin intoxication in critically ill patients.Precision Fluid Management in Continuous Renal Replacement Therapy.Diagnosis of cardiac surgery-associated acute kidney injury from functional to damage biomarkers.
P50
Q24801686-E55E6240-7D72-4629-AFF7-0E2126C3839AQ26753861-AC2EAB1B-0953-4174-B146-7FC7B660BE4CQ26765781-EED9FCC3-74C2-44C8-9D69-94EBCF186B91Q26853350-A729A663-F976-40FC-B9DA-A3832BBDE850Q30234560-1805DB62-117A-462F-B9E1-08873DEF5DAEQ30253084-605C0B77-FFBF-4591-A2AC-CCAC0884ED2CQ33388003-82933D32-C65D-43DB-8986-69F9AB0CED36Q33751132-045BC8FF-49C7-48C9-9014-1DFE0A42FEAFQ33753534-EA5F001F-F2B7-4854-96DB-87FFDCD1BA34Q33843623-CE245E11-D114-42C8-A341-45082C12E1ABQ34112748-55E7D42C-6535-4CEC-A6AC-CDC7C41ACA32Q34155402-B2C5E4C0-D334-4A66-99BD-1AF2AE0BEBEBQ34385638-F4939F7E-6FF4-4261-BB19-AD860AA9E780Q34406897-55862C27-367C-4344-BCE8-6BDA5EFAEFDCQ34624497-14584046-132D-4F1D-AB56-DECCC2044763Q35092085-6FAF0EE3-2717-4C4A-BA70-EDBFFE48C212Q35790577-2F96E3D5-1589-4554-8D56-BF5EDADEA2BDQ35841169-AB901E5E-F7BF-49E2-ACE6-845FB60BB5FFQ35841245-C3DB213D-2A16-4267-89D5-DBA36E60A620Q36076376-A4234CDE-14AA-4391-B2E6-5EADC3ED4B35Q36088502-00EE85B9-D82D-40E3-942C-916F67BDA3CBQ36392700-CD9E8B1E-BFC9-4FAD-802A-9BCEB2CFC4B4Q36434034-F0B92A85-9880-4A36-932D-5A27618ECB56Q36488210-E32A1234-1245-4E6C-B14D-72934A07E0E7Q36570193-AA58B167-4387-46B8-90CB-0BAA9238AF91Q36634015-872E4E9B-ACB4-4D8F-9369-47CD42CB5700Q36640738-96A105AA-974A-4764-8A3F-5F44D08E0C72Q36803516-07125EE7-08A4-4EA3-8362-CB3CC55FA010Q37098841-DB0B6766-E37F-43FE-BD5F-BE3C5B76F0ACQ37125697-21D4A384-DB71-4FE1-A850-5B97962998C9Q37196880-FEFBE8D6-7D0E-413D-A9BB-46ED77AC3A8AQ37640336-331CBB4E-E04C-4FAF-96D1-C8C721C6726EQ37932941-2D3C7A5A-FCA1-4E7C-95D8-9EC9BD0CF1A7Q38108195-9430345B-5CD3-4B16-88E6-948F64F2E5FFQ38108198-CEF769FC-2A7A-47CA-9E54-7CCFB1482AB9Q38247514-BEF14CAC-6369-4589-AC25-14BB1A53D694Q38260127-24C8C4EC-4F5D-42B0-A7C1-98960BAF0159Q38489418-7CD5F4E4-F190-4CB7-BCEE-FF5D0D895D6FQ38827759-A726D431-C242-45BF-8FEC-B2688FBD17B2Q39025776-D63D791C-9E9E-477F-B9ED-B583F9BF222B
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Eric A Hoste
@nl
Eric A Hoste
@sl
Eric A. Hoste
@en
Eric A. Hoste
@es
type
label
Eric A Hoste
@nl
Eric A Hoste
@sl
Eric A. Hoste
@en
Eric A. Hoste
@es
prefLabel
Eric A Hoste
@nl
Eric A Hoste
@sl
Eric A. Hoste
@en
Eric A. Hoste
@es
P108
P1053
A-6353-2008
P106
P1153
7003321817
P21
P31
P3829
P496
0000-0001-9301-8055